Civic Intelligence

Neurodegenerative Disease Researchinc

EIN 85-0520661 • 501(c)3 • Reddick, FL

Profile

Our goal is to facilitate research that will bring new treatments to those suffering from neurodegenerative diseases. We fund researchers that have projects intended to bring new hope to ALS patients.

15471 NW 112th AveReddick, FL 32686

ndric.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

21st percentile

0.00x

Higher debt load relative to assets than 21% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Liabilities / Revenue

20th percentile

0.00x

Higher debt load relative to revenue than 20% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Net Margin

43rd percentile

1.3%

Higher net margin than 43% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Top Officer Pay

82nd percentile

$150,000

Higher top officer pay than 82% of similar nonprofits.

Top officer pay equals 9.6% of source-year revenue.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Asset Growth

64th percentile

9.2%

Faster asset growth than 64% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Revenue Growth

20th percentile

-14%

Faster revenue growth than 20% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Assets

Up

$248,396

Up $20,871 (+9.2%) from 2023

Liabilities

Down

$161

Down $25 (-13%) from 2023

Net Assets

Up

$248,235

Up $20,896 (+9.2%) from 2023

Revenue

Down

$1,561,118

Down $253,207 (-14%) from 2023

Expenses

Down

$1,540,222

Down $598,669 (-28%) from 2023

Net Income

Up

$20,896

Up $345,462 (+106%) from 2023

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$1.5M$1.0M$500K$0Assets 2020: $1,063,188Liabilities 2020: $3,436Net Assets 2020: $1,059,7522020Assets 2021: $603,568Liabilities 2021: $93Net Assets 2021: $603,4752021Assets 2022: $563,346Liabilities 2022: $11,441Net Assets 2022: $551,9052022Assets 2023: $227,525Liabilities 2023: $186Net Assets 2023: $227,3392023Assets 2024: $248,396Liabilities 2024: $161Net Assets 2024: $248,2352024

Highlighted filing

2024

Assets$248,396
Liabilities$161
Net Assets$248,235

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$6.0M$4.0M$2.0M$0-$2.0MRevenue 2020: $3,250,647Expenses 2020: $2,190,895Net Income 2020: $1,059,7522020Revenue 2021: $3,928,115Expenses 2021: $4,384,392Net Income 2021: -$456,2772021Revenue 2022: $4,274,249Expenses 2022: $4,380,443Net Income 2022: -$106,1942022Revenue 2023: $1,814,325Expenses 2023: $2,138,891Net Income 2023: -$324,5662023Revenue 2024: $1,561,118Expenses 2024: $1,540,222Net Income 2024: $20,8962024

Highlighted filing

2024

Revenue$1,561,118
Expenses$1,540,222
Net Income$20,896

Filings

Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Jun 11, 2025
Return Version
2024v5.1
Gross Receipts
$1,561,118
Mission and Program Overview

Mission

Our goal is to facilitate research that will bring new treatments to those suffering from neurodegenerative diseases. We fund researchers that have projects intended to bring new hope to ALS patients.

Balance Sheet Detail
LineBeginningEndChange
Assets
Land, Buildings, and Equipment, Net$158,844$158,844→ $0
Cash and Non-Interest-Bearing Accounts$68,681$89,552▲ $20,871
Total Assets$227,525$248,396▲ $20,871
Liabilities
Accounts Payable and Accrued Expenses$186$161▼ $25
Total Liabilities$186$161▼ $25
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$227,339$248,235▲ $20,896
Total Net Assets Fund Balance$227,339$248,235▲ $20,896
Total Liabilities and Net Assets / Fund Balance$227,525$248,396▲ $20,871

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$158,844-$158,844
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseTotal
Siobhan EllisonPresident and CEOFT$150,000$150,000

Board Members and Trustees

NameTitle
Bill KilleenVice President
Julie OsborneBoard Member

Highest Paid Contractors

ContractorServicesLocationCompensation
Hesperos IncDrug Develop Svc12501 Research Pkwy Unit 100, Orlando, FL 32826$395,810
Xenobiotic LaboratoriesDrug Develop Svc107 Morgan Lane, Plainsboro, NJ 08536$143,280
Revenue and Support

Revenue Composition

Contributions and Grants
$1,561,118
Program Service Revenue
$0
Investment Income
$0
Other Revenue
$0
All Other Contributions
$1,561,118
Change in Net Assets
$20,896
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$742,929
Other Expenses$635,806
Salaries, Compensation, and Employee Benefits$161,487
Total Fundraising Expense$3,493
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$615,818--$615,818
Other Expenses$454,632--$454,632
Current Officers, Directors, Trustees, and Key Employees$135,000$12,000$3,000$150,000
Fees for Services Other$136,662$7,193-$143,855
Foreign Grants$127,111--$127,111
Fees for Services Legal$20,600--$20,600
Office Expenses$11,833$1,052$263$13,148
Payroll Taxes$10,338$919$230$11,487
Fees for Services Accounting-$3,571-$3,571
Total Functional Expenses$1,511,994$24,735$3,493$1,540,222
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Rho Worldwide IncDurham, NC501c3Medical research$609,817
University of Florida Research FounGainesville, FL-Medical research$6,000

International Compliance

Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Officer directors etc family relationship Part VI line 2

Siobhan Ellison and Bill Killeen have a family relationship.

Committee meeting documentation Part VI line 8B

There are no committees with authority to act on behalf of the Board of Directors.

Form 990 governing body review Part VI line 11

The Form 990 is completed with the assistance of a Certified Public Accountant and is reviewed and signed by the President and CEO. A copy of the Form 990 is provided to all board memebers before it is filed.

Conflict of interest policy compliance Part VI line 12C

NDR has a limited number of board members whose family members and related entities are well known to all other members of the board. The president and CEO is familiar with all transactions and would fully disclose any transactions that might be considered a conflict of interest. NDR has not entered into any transactions that might be considered a conflict of interest.

CEO executive director top management comp Part VI line 15A

NDR has a compensation policy which states that the compensation package results from substantive evaluation by a compensation committee. The documentation which determined the salary package was obtained from multiple sources and was filed in the corporation minutes.

Governing documents etc available to public Part VI line 19

Governing documents are available to the public upon request.

Filing and Contact Details

Filer

Filer Name
Neurodegenerative Disease ResearchInc
EIN
85-0520661
In Care Of
% Siobhan Ellison
Phone
3522145209
Address
15471 NW 112th Ave, Reddick, FL 32686

Signing Officer

Name
Siobhan Ellison
Title
President and CEO
Phone
3522145209
Signed
2025-06-11
Discuss with paid preparer
No

Organization Details

Principal Officer
Siobhan Ellison
Formed
2020
Legal Domicile
Fl
Voting Board Members
3
Independent Board Members
3
Employees
0
Volunteers
2

Preparer

Firm
Kattell and Company PL
Address
808-B NW 16th Avenue, Gainesville, FL 32601
Preparer
Stephen H Kattell
Phone
3523956565
Raw XML Appendix364 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt0186
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt0161
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0Our goal is to facilitate research that will bring new treatments to those suffering from neurodegenerative diseases. We fund researchers that have projects intended to bring new hope to ALS patients.
IRS990/AllOtherContributionsAmt01561118
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/BackupWthldComplianceInd0true
IRS990/BooksInCareOfDetail/PersonNm0Sharon Brannan
IRS990/BooksInCareOfDetail/PhoneNum08776359157
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0161 N Main St
IRS990/BooksInCareOfDetail/USAddress/CityNm0Williston
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0FL
IRS990/BooksInCareOfDetail/USAddress/ZIPCd032696
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt068681
IRS990/CashNonInterestBearingGrp/EOYAmt089552
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CntrctRcvdGreaterThan100KCnt02
IRS990/CollectionsOfArtInd0false
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt03000
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt012000
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0135000
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0150000
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0true
IRS990/CompensationProcessOtherInd0false
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/ContractorCompensationGrp/CompensationAmt0395810
IRS990/ContractorCompensationGrp/CompensationAmt1143280
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt012501 Research Pkwy Unit 100
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt1107 Morgan Lane
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0Orlando
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm1Plainsboro
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0FL
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd1NJ
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd032826
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd108536
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0Hesperos Inc
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt1Xenobiotic Laboratories
IRS990/ContractorCompensationGrp/ServicesDesc0Drug Develop Svc
IRS990/ContractorCompensationGrp/ServicesDesc1Drug Develop Svc
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01561118
IRS990/CYGrantsAndSimilarPaidAmt0742929
IRS990/CYInvestmentIncomeAmt00
IRS990/CYOtherExpensesAmt0635806
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt020896
IRS990/CYSalariesCompEmpBnftPaidAmt0161487
IRS990/CYTotalExpensesAmt01540222
IRS990/CYTotalFundraisingExpenseAmt03493
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt01561118
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/Desc0Our mission is to fund researchers with an emphasis to identify and validate biomarkers for determining drug effectiveness in neurodegenerative diseases and facilitate pathology-based treatments to ALS patients.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0true
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRstrOrQuasiEndowmentsInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt01511994
IRS990/FamilyOrBusinessRlnInd0true
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt03571
IRS990/FeesForServicesAccountingGrp/TotalAmt03571
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt020600
IRS990/FeesForServicesLegalGrp/TotalAmt020600
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt07193
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0136662
IRS990/FeesForServicesOtherGrp/TotalAmt0143855
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignGrantsGrp/ProgramServicesAmt0127111
IRS990/ForeignGrantsGrp/TotalAmt0127111
IRS990/ForeignOfficeInd0false
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt00.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt10.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt20.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt16.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt26.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/PersonNm0Siobhan Ellison
IRS990/Form990PartVIISectionAGrp/PersonNm1Julie Osborne
IRS990/Form990PartVIISectionAGrp/PersonNm2Bill Killeen
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0150000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/TitleTxt0President and CEO
IRS990/Form990PartVIISectionAGrp/TitleTxt1Board Member
IRS990/Form990PartVIISectionAGrp/TitleTxt2Vice President
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr02020
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt03
IRS990/GrantAmt0742929
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0615818
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0615818
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0true
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt01561118
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt03
IRS990/IndivRcvdGreaterThan100KCnt01
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InvestmentInJointVentureInd0false
IRS990/IRPDocumentCnt01
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipBasisNetGrp/BOYAmt0158844
IRS990/LandBldgEquipBasisNetGrp/EOYAmt0158844
IRS990/LandBldgEquipCostOrOtherBssAmt0158844
IRS990/LegalDomicileStateCd0FL
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingCashInd0X
IRS990/MinutesOfCommitteesInd0false
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0Our goal is to facilitate research that will bring new treatments to those suffering from neurodegenerative diseases. We fund researchers that have projects intended to bring new hope to ALS patients.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0true
IRS990/NetAssetsOrFundBalancesBOYAmt0227339
IRS990/NetAssetsOrFundBalancesEOYAmt0248235
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt00
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt0227339
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt0248235
IRS990/NondeductibleContributionsInd0false
IRS990/OfficeExpensesGrp/FundraisingAmt0263
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt01052
IRS990/OfficeExpensesGrp/ProgramServicesAmt011833
IRS990/OfficeExpensesGrp/TotalAmt013148
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherExpensesGrp/Desc0Drug Manufacturing Exp
IRS990/OtherExpensesGrp/ProgramServicesAmt0454632
IRS990/OtherExpensesGrp/TotalAmt0454632
IRS990/PartialLiquidationInd0false
IRS990/PayPremiumsPrsnlBnftCntrctInd0false
IRS990/PayrollTaxesGrp/FundraisingAmt0230
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt0919
IRS990/PayrollTaxesGrp/ProgramServicesAmt010338
IRS990/PayrollTaxesGrp/TotalAmt011487
IRS990/PoliticalCampaignActyInd0false
IRS990/PrincipalOfficerNm0Siobhan Ellison
IRS990/ProfessionalFundraisingInd0false
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYContributionsGrantsAmt01814296
IRS990/PYExcessBenefitTransInd0false
IRS990/PYGrantsAndSimilarPaidAmt01792755
IRS990/PYInvestmentIncomeAmt029
IRS990/PYOtherExpensesAmt0133141
IRS990/PYRevenuesLessExpensesAmt0-324566
IRS990/PYSalariesCompEmpBnftPaidAmt0212995
IRS990/PYTotalExpensesAmt02138891
IRS990/PYTotalRevenueAmt01814325
IRS990/QuidProQuoContributionsInd0false
IRS990/RcvFndsToPayPrsnlBnftCntrctInd0false
IRS990/ReconcilationRevenueExpnssAmt020896
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0false
IRS990/ReportProgramRelatedInvstInd0false
IRS990ScheduleA/First5Years170Ind0X
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt01561118
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt01814296
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt04273976
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt03927624
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt03250000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt014827014
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt029
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0273
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0491
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt0647
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt01440
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportTotal170Amt09324118
IRS990ScheduleA/SubstantialContributorsTotAmt05502896
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt01561118
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt01814296
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt04273976
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt03927624
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt03250000
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt014827014
IRS990ScheduleA/TotalSupportAmt014828454
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd0true
IRS990ScheduleD/EquipmentGrp/BookValueAmt0158844
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt0158844
IRS990ScheduleD/TotalBookValueLandBuildingsAmt0158844
IRS990ScheduleF/BoycottCountriesInd0false
IRS990ScheduleF/ForeignCorpOwnershipInd0false
IRS990ScheduleF/ForeignPartnershipInd0false
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt0127111
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt0Cashiers check
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt0Medical Research
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt0East Asia and the Pacific
IRS990ScheduleF/InterestInForeignTrustInd0false
IRS990ScheduleF/PassiveForeignInvestmestCoInd0false
IRS990ScheduleF/SupplementalInformationDetail/ExplanationTxt0NDR collaborates with research institutions and organizations to fund research with the greatest likelihood of impact in the effort to treat patients with ALS. Funded organizations are selected for their unique expertise, novel capabilities and approach, and a track record supported by published research. The amount of funding is based on detailed budgets. NDR is in continuous contact with the principal investigators as research progress and results are shared.
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc0Use of grant monitoring procedures (Part I, line 2)
IRS990ScheduleF/TransferToForeignCorpInd0false
IRS990ScheduleI/GrantRecordsMaintainedInd0true
IRS990ScheduleI/RecipientTable/CashGrantAmt0609817
IRS990ScheduleI/RecipientTable/CashGrantAmt16000
IRS990ScheduleI/RecipientTable/IRCSectionDesc0501c3
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0Medical research
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt1Medical research
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0Rho Worldwide Inc
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt1University of Florida Research Foun
IRS990ScheduleI/RecipientTable/RecipientEIN0999999999
IRS990ScheduleI/RecipientTable/RecipientEIN1592729133
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt02635 E NC Hwy 54
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt1Grinter Hall 1523 Union Rd
IRS990ScheduleI/RecipientTable/USAddress/CityNm0Durham
IRS990ScheduleI/RecipientTable/USAddress/CityNm1Gainesville
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0NC
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd1FL
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd027713
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd132601
IRS990ScheduleI/SupplementalInformationDetail/ExplanationTxt0NDR collaborates with research institutions and organizations to fund research with the greatest likelihood of impact in the effort to treat patients with ALS. Funded organizations are selected for their unique expertise, novel approach, and a track record supported by published research. The amount of funding is based on detailed detailed budgets. NDR is in continuous contact with the principal investigators as research progress and results are shared.
IRS990ScheduleI/SupplementalInformationDetail/FormAndLineReferenceDesc0Monitoring procedures (Part I, line 2)
IRS990/ScheduleJRequiredInd0false
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Siobhan Ellison and Bill Killeen have a family relationship.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1There are no committees with authority to act on behalf of the Board of Directors.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2The Form 990 is completed with the assistance of a Certified Public Accountant and is reviewed and signed by the President and CEO. A copy of the Form 990 is provided to all board memebers before it is filed.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3NDR has a limited number of board members whose family members and related entities are well known to all other members of the board. The president and CEO is familiar with all transactions and would fully disclose any transactions that might be considered a conflict of interest. NDR has not entered into any transactions that might be considered a conflict of interest.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4NDR has a compensation policy which states that the compensation package results from substantive evaluation by a compensation committee. The documentation which determined the salary package was obtained from multiple sources and was filed in the corporation minutes.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5Governing documents are available to the public upon request.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Officer directors etc family relationship Part VI line 2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Committee meeting documentation Part VI line 8b
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Form 990 governing body review Part VI line 11
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Conflict of interest policy compliance Part VI line 12c
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4CEO executive director top management comp Part VI line 15a
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5Governing documents etc available to public Part VI line 19
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0FL
IRS990/SubjectToExcsTaxNetInvstIncInd0false
IRS990/SubjectToProxyTaxInd0false
IRS990/SubjToTaxRmnrtnExPrchtPymtInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt0227525
IRS990/TotalAssetsEOYAmt0248396
IRS990/TotalAssetsGrp/BOYAmt0227525
IRS990/TotalAssetsGrp/EOYAmt0248396
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalContributionsAmt01561118
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt03493
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt024735
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt01511994
IRS990/TotalFunctionalExpensesGrp/TotalAmt01540222
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt0186
IRS990/TotalLiabilitiesEOYAmt0161
IRS990/TotalLiabilitiesGrp/BOYAmt0186
IRS990/TotalLiabilitiesGrp/EOYAmt0161
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0227339
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0248235
IRS990/TotalOtherCompensationAmt00
IRS990/TotalProgramServiceExpensesAmt01511994
IRS990/TotalReportableCompFromOrgAmt0150000
IRS990/TotalRevenueGrp/ExclusionAmt00
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt01561118
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/TotalVolunteersCnt02
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0227525
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt0248396
IRS990/TotReportableCompRltdOrgAmt00
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt015471 NW 112th Ave
IRS990/USAddress/CityNm0Reddick
IRS990/USAddress/StateAbbreviationCd0FL
IRS990/USAddress/ZIPCd032686
IRS990/VotingMembersGoverningBodyCnt03
IRS990/VotingMembersIndependentCnt03
IRS990/WebsiteAddressTxt0ndric.org
IRS990/WhistleblowerPolicyInd0true
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0false
ReturnHeader/BusinessOfficerGrp/PersonNm0SIOBHAN ELLISON
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0President and CEO
ReturnHeader/BusinessOfficerGrp/PhoneNum03522145209
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-06-11
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0Neurodegenerative Disease ResearchInc
ReturnHeader/Filer/BusinessNameControlTxt0NEUR
ReturnHeader/Filer/EIN0850520661
ReturnHeader/Filer/InCareOfNm0% Siobhan Ellison
ReturnHeader/Filer/PhoneNum03522145209
ReturnHeader/Filer/USAddress/AddressLine1Txt015471 NW 112th Ave
ReturnHeader/Filer/USAddress/CityNm0Reddick
ReturnHeader/Filer/USAddress/StateAbbreviationCd0FL
ReturnHeader/Filer/USAddress/ZIPCd032686
ReturnHeader/IRSResponsiblePrtyInfoCurrInd0true
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0010822046
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0Kattell and Company PL
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0808-B NW 16th Avenue
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0Gainesville
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0FL
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd032601
ReturnHeader/PreparerPersonGrp/PhoneNum03523956565
ReturnHeader/PreparerPersonGrp/PreparationDt02025-06-30
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0STEPHEN H KATTELL
ReturnHeader/ReturnTs02025-06-30T11:01:23-04:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.